Serum HBsAg levels and their utility as a predictor of sustained virological response after antiviral treatment

Peter Karayiannis

doi:10.5812/hepatmon.859

Serum HBsAg levels and their utility as a predictor of sustained virological response after antiviral treatment

Peter Karayiannis

Medical School

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	24-26
Number of pages	3
Journal	Hepatitis Monthly
Volume	12
Issue number	7
DOIs	https://doi.org/10.5812/hepatmon.859
Publication status	Published - Jul 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HBsAg
Hepatitis B
Serum

Access to Document

10.5812/hepatmon.859

Cite this

@article{f89be846b99a43b896ec355364ae936a,

title = "Serum HBsAg levels and their utility as a predictor of sustained virological response after antiviral treatment",

keywords = "HBsAg, Hepatitis B, Serum",

author = "Peter Karayiannis",

year = "2012",

month = jul,

doi = "10.5812/hepatmon.859",

language = "English",

volume = "12",

pages = "24--26",

journal = "Hepatitis Monthly",

issn = "1735-143X",

publisher = "Brieflands",

number = "7",

}

TY - JOUR

T1 - Serum HBsAg levels and their utility as a predictor of sustained virological response after antiviral treatment

AU - Karayiannis, Peter

PY - 2012/7

Y1 - 2012/7

KW - HBsAg

KW - Hepatitis B

KW - Serum

UR - https://www.scopus.com/pages/publications/84864267725

U2 - 10.5812/hepatmon.859

DO - 10.5812/hepatmon.859

M3 - Editorial

AN - SCOPUS:84864267725

SN - 1735-143X

VL - 12

SP - 24

EP - 26

JO - Hepatitis Monthly

JF - Hepatitis Monthly

IS - 7

ER -

Serum HBsAg levels and their utility as a predictor of sustained virological response after antiviral treatment

UN SDGs

Keywords

Access to Document

Other files and links

Cite this